Akebia Therapeutics (AKBA) Retained Earnings (2013 - 2026)
Akebia Therapeutics (AKBA) reported Retained Earnings of $6000.0 for Q1 2026, little changed year-over-year from $6000.0 in Q1 2025, and up 100.0% quarter-over-quarter from -$1.7 billion in Q4 2025.
Akebia Therapeutics (AKBA) Retained Earnings (2013 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has 14 years of Retained Earnings data on file, last reported at $6000.0 in Q1 2026.
- Retained Earnings for Q1 2026 came in at $6000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $6000.0 (changed 0.0% YoY), and the FY2025 annual result was -$1.7 billion, down 28061850.0% from the prior year.
- Retained Earnings climbed to $6000.0 in Q1 2026 per AKBA's latest filing, from -$1.7 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $6000.0 in Q3 2023 and troughed at -$1.7 billion in Q4 2025.
- A 5-year average of -$837.5 million and a median of -$1.5 billion in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2023 and 2025: Retained Earnings jumped 100.0% in 2023, then tumbled 28061850.0% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$1.6 billion in 2022, then retreated by 3.33% to -$1.6 billion in 2023, then surged by 100.0% to $6000.0 in 2024, then plunged by 28061850.0% to -$1.7 billion in 2025, then soared by 100.0% to $6000.0 in 2026.
- Business Quant data shows AKBA's Retained Earnings at $6000.0 in Q1 2026, -$1.7 billion in Q4 2025, and $6000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Akebia Therapeutics | 243.23 Mn | 80.63 Mn | 41.25 Mn | 6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,000.00 |
| Dec 31, 2025 | -1.68 Bn |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | -1.64 Bn |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | -1.61 Bn |
| Sep 30, 2023 | 6,000.00 |
| Jun 30, 2023 | -1.60 Bn |
| Mar 31, 2023 | -1.58 Bn |
| Dec 31, 2022 | -1.56 Bn |
| Sep 30, 2022 | -1.55 Bn |
| Jun 30, 2022 | -1.50 Bn |
| Mar 31, 2022 | -1.53 Bn |
| Dec 31, 2021 | -1.46 Bn |
| Sep 30, 2021 | -1.39 Bn |
| Jun 30, 2021 | -1.33 Bn |